22,23-dihydrobrassicasterol

22,23-dihydrobrassicasterol is a lipid of Sterol Lipids (ST) class. 22,23-dihydrobrassicasterol is associated with abnormalities such as Diabetes, Macular degeneration, Drusen, Systemic disease and Diabetes Mellitus. The involved functions are known as cholesterol metabolism, Synthesis, Intestinal Absorption, Liver function and cholesterol absorption. 22,23-dihydrobrassicasterol often locates in Back and Cell membrane. The associated genes with 22,23-dihydrobrassicasterol are apolipoprotein E-3. The related lipids are Total cholesterol, campesterol, lathosterol, Fatty Acids, Nonesterified and Cholesterol, Dietary.

Cross Reference

Introduction

To understand associated biological information of 22,23-dihydrobrassicasterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 22,23-dihydrobrassicasterol?

22,23-dihydrobrassicasterol is suspected in Diabetes, Macular degeneration, Drusen, Systemic disease, Diabetes Mellitus, Liver diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 22,23-dihydrobrassicasterol

MeSH term MeSH ID Detail
Coronary Disease D003327 70 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hypolipoproteinemias D007009 9 associated lipids
Xanthomatosis D014973 17 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 22,23-dihydrobrassicasterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 22,23-dihydrobrassicasterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 22,23-dihydrobrassicasterol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 22,23-dihydrobrassicasterol

Download all related citations
Per page 10 20 50 100 | Total 313
Authors Title Published Journal PubMed Link
Lembcke J et al. Rapid quantification of free and esterified phytosterols in human serum using APPI-LC-MS/MS. 2005 J. Lipid Res. pmid:15489546
Plat J et al. Common sequence variations in ABCG8 are related to plant sterol metabolism in healthy volunteers. 2005 J. Lipid Res. pmid:15520451
Nikkilä K et al. Sterol parameters as markers of liver function in primary biliary cirrhosis before and after liver transplantation. 2005 Transpl. Int. pmid:15691276
Yokosuka A et al. New glycosides of the campesterol derivative from the rhizomes of Tacca chantrieri. 2005 Steroids pmid:15784281
Yu L et al. Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8. 2005 J. Lipid Res. pmid:15930515
Miettinen TA et al. Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. 2005 J. Am. Coll. Cardiol. pmid:15936608
Hong Z et al. The Rice brassinosteroid-deficient dwarf2 mutant, defective in the rice homolog of Arabidopsis DIMINUTO/DWARF1, is rescued by the endogenously accumulated alternative bioactive brassinosteroid, dolichosterone. 2005 Plant Cell pmid:15994910
Päivä H et al. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. 2005 Clin. Pharmacol. Ther. pmid:16003294
Sutherland WH et al. Plasma non-cholesterol sterols in patients with non-insulin dependent diabetes mellitus. 1992 Horm. Metab. Res. pmid:1601392
Awad AB et al. beta-Sitosterol stimulates ceramide metabolism in differentiated Caco2 cells. 2005 J. Nutr. Biochem. pmid:16098730
Ho SS and Pal S Margarine phytosterols decrease the secretion of atherogenic lipoproteins from HepG2 liver and Caco2 intestinal cells. 2005 Atherosclerosis pmid:16115472
Conchillo A et al. Levels of phytosterol oxides in enriched and nonenriched spreads: application of a thin-layer chromatography-gas chromatography methodology. 2005 J. Agric. Food Chem. pmid:16190640
Xu F et al. Dual roles for cholesterol in mammalian cells. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:16199524
Takahashi K et al. Metabolic conversion of 24-methyl-Delta25-cholesterol to 24-methylcholesterol in higher plants. 2006 Bioorg. Med. Chem. pmid:16213729
de Jong A et al. Plant sterol or stanol consumption does not affect erythrocyte osmotic fragility in patients on statin treatment. 2006 Eur J Clin Nutr pmid:16482072
Hedman M et al. Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy. 2006 J. Pediatr. pmid:16492436
Takahashi K et al. Purification and ATPase activity of human ABCA1. 2006 J. Biol. Chem. pmid:16500904
Sorenson WR and Sullivan D Determination of campesterol, stigmasterol, and beta-sitosterol in saw palmetto raw materials and dietary supplements by gas chromatography: single-laboratory validation. 2006 Jan-Feb J AOAC Int pmid:16512224
Gerloff T et al. Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levels. 2006 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16568260
Ikeda I et al. Campest-5-en-3-one, an oxidized derivative of campesterol, activates PPARalpha, promotes energy consumption and reduces visceral fat deposition in rats. 2006 Biochim. Biophys. Acta pmid:16616424